Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(0.59) per share. This is a 11.32 percent decrease over losses of $(0.53) per share from the same period last year.
US Default Would Be a Lose-Lose for Housing, Predict Analysts: Mortgages to Surge 22%, Prices to Remain High
In the event Congress fails to lift or suspend the debt ceiling which would cause the United States…